unknown
Stage
2019
Founded
1
Investors
About
ViAn Therapeutics develops a topical eye drop treatment that inhibits angiogenesis and inflammation to treat retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), providing a non-invasive alternative to intravitreal injections.
Explore ViAn Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.